Search research articles
Contact Us
Filters
Showing results (31-40 of 367) with videos related to
Page
of 37
Sort By:
Oncoimmunology
|
February 6, 2014
Harnessing the antitumor potential of macrophages for cancer immunotherapy
Kristen B Long, Gregory L Beatty
Journal of Leukocyte Biology
|
April 10, 2020
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
Renee B Chang, Gregory L Beatty
Infection and Immunity
|
November 14, 1997
Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes
W L Beatty, P J Sansonetti
Microvascular Research
|
January 2, 2007
Modeling of oxygen transport across tumor multicellular layers
Rod D Braun, Alexis L Beatty
Pharmacology & Therapeutics
|
June 4, 2019
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L Stone, Gregory L Beatty
Seminars in Ophthalmology
|
September 1, 1994
Complex facial fractures in the periorbital region
M W Ochs, R L Beatty
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology
|
October 7, 2003
Patterns of control of maximum metabolic rate in humans
Peter W Hochachka, Cheryl L Beatty
Annual Review of Pathology
|
September 21, 2022
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H Sherman, Gregory L Beatty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Facts and Hopes of CD40 Agonists in Cancer Immunotherapy
John C McVey, Gregory L Beatty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2017
Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance
Gregory L Beatty, Shabnam Eghbali, Rebecca Kim
Page
of 37
Search research articles
Search
Showing results (31-40 of 367) with videos related to
Sort By:
Page
of 37
Oncoimmunology
|
February 6, 2014
Harnessing the antitumor potential of macrophages for cancer immunotherapy
Kristen B Long, Gregory L Beatty
Journal of Leukocyte Biology
|
April 10, 2020
The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
Renee B Chang, Gregory L Beatty
Infection and Immunity
|
November 14, 1997
Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes
W L Beatty, P J Sansonetti
Microvascular Research
|
January 2, 2007
Modeling of oxygen transport across tumor multicellular layers
Rod D Braun, Alexis L Beatty
Pharmacology & Therapeutics
|
June 4, 2019
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Meredith L Stone, Gregory L Beatty
Seminars in Ophthalmology
|
September 1, 1994
Complex facial fractures in the periorbital region
M W Ochs, R L Beatty
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology
|
October 7, 2003
Patterns of control of maximum metabolic rate in humans
Peter W Hochachka, Cheryl L Beatty
Annual Review of Pathology
|
September 21, 2022
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H Sherman, Gregory L Beatty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 21, 2025
Facts and Hopes of CD40 Agonists in Cancer Immunotherapy
John C McVey, Gregory L Beatty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 1, 2017
Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance
Gregory L Beatty, Shabnam Eghbali, Rebecca Kim
Page
of 37